Generics in Asia-Pacific - Market Summary, Competitive Analysis and Forecast to 2025

Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The Asia-Pacific generics market had total revenues of $136.0bn in 2020, representing a compound annual growth rate (CAGR) of 6.5% between 2016 and 2020.
Market consumption volume increased with a CAGR of 2.7% between 2016 and 2020, to reach a total of 85.3% in 2020.
The key factors driving the growth of generic drug market in China are rising healthcare awareness, a large and aging population, several healthcare reforms, and reductions in generic drug prices.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Asia-Pacific
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Asia-Pacific
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific generics market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Asia-Pacific generics market by value in 2020?
What will be the size of the Asia-Pacific generics market in 2025?
What factors are affecting the strength of competition in the Asia-Pacific generics market?
How has the market performed over the last five years?
How large is Asia-Pacific’s generics market in relation to its regional counterparts?

Frequently Asked Questions about the Generics in Asia-Pacific Market

What is the estimated value of the Generics in Asia-Pacific Market?

The Generics in Asia-Pacific Market was estimated to be valued at $135.97 Billion in 2020.

What is the growth rate of the Generics in Asia-Pacific Market?

The growth rate of the Generics in Asia-Pacific Market is 5.8%, with an estimated value of $180.97 Billion by 2025.

What is the forecasted size of the Generics in Asia-Pacific Market?

The Generics in Asia-Pacific Market is estimated to be worth $180.97 Billion by 2025.

Who are the key companies in the Generics in Asia-Pacific Market?

Key companies in the Generics in Asia-Pacific Market include Teva Pharmaceutical Industries Limited, Viatris Inc. and Pfizer Inc..

Report Attribute	Details
No. of Pages	44
Published	July 2021
Forecast Period	2020 - 2025
Estimated Market Value ( USD ) in 2020	$ 135.97 Billion
Forecasted Market Value ( USD ) by 2025	$ 180.97 Billion
Compound Annual Growth Rate	5.8%
Regions Covered	Asia Pacific

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value
3.2. Market volume

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?

8 Company Profiles

8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Sun Pharmaceutical Industries Ltd
8.4. Pfizer Inc.

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Author

List of Tables

Table 1: Asia-Pacific generics market value: $ billion, 2016-20
Table 2: Asia-Pacific generics market volume: %, 2016-20
Table 3: Asia-Pacific generics market geography segmentation: $ billion, 2020
Table 4: Asia-Pacific generics market value forecast: $ billion, 2020-25
Table 5: Asia-Pacific generics market volume forecast: %, 2020-25
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Sun Pharmaceutical Industries Ltd: key facts
Table 13: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 14: Sun Pharmaceutical Industries Ltd: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: Asia-Pacific exchange rate, 2016-20

List of Figures

Figure 1: Asia-Pacific generics market value: $ billion, 2016-20
Figure 2: Asia-Pacific generics market volume: %, 2016-20
Figure 3: Asia-Pacific generics market geography segmentation: % share, by value, 2020
Figure 4: Asia-Pacific generics market value forecast: $ billion, 2020-25
Figure 5: Asia-Pacific generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Asia-Pacific, 2020
Figure 7: Drivers of buyer power in the generics market in Asia-Pacific, 2020
Figure 8: Drivers of supplier power in the generics market in Asia-Pacific, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2020

Companies Mentioned

A selection of companies mentioned in this report includes:

Teva Pharmaceutical Industries Limited
Viatris Inc.
Sun Pharmaceutical Industries Ltd
Pfizer Inc.

What is the estimated value of the Generics in Asia-Pacific Market?

What is the growth rate of the Generics in Asia-Pacific Market?

What is the forecasted size of the Generics in Asia-Pacific Market?

Who are the key companies in the Generics in Asia-Pacific Market?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Asia-Pacific Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Asia Pacific Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication, By Distribution Channel, By Demographics, By Country and Growth Forecast, 2022 - 2028

Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Industry Trends Analysis Report By End-user, By Indication, By Distribution Channel, By Demographics, By Regional Outlook and Forecast, 2022 - 2028